|
|
Volumn 78, Issue 2, 2008, Pages 210-211
|
|
Short report: Efficacy of miltefosine for Bolivian cutaneous leishmaniasis
b
c
c
b
b
d
a,e
a
Fundación FADER
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MEGLUMINE ANTIMONATE;
MILTEFOSINE;
ANTIPROTOZOAL AGENT;
DRUG DERIVATIVE;
MEGLUMINE;
MEGLUMINE ANTIMONIATE;
ORGANOMETALLIC COMPOUND;
PHOSPHORYLCHOLINE;
UNCLASSIFIED DRUG;
ADULT;
ARTHRALGIA;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
FOLLOW UP;
GASTROINTESTINAL SYMPTOM;
HUMAN;
INJECTION SITE PAIN;
LEISHMANIA BRAZILIENSIS;
MAJOR CLINICAL STUDY;
MALE;
SKIN LEISHMANIASIS;
STATISTICAL SIGNIFICANCE;
TREATMENT DURATION;
ADOLESCENT;
ANIMAL;
BOLIVIA;
CHILD;
CONTROLLED CLINICAL TRIAL;
DRUG EFFECT;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
TIME;
TREATMENT OUTCOME;
LEISHMANIA BRAZILIENSIS;
ADOLESCENT;
ADULT;
ANIMALS;
ANTIPROTOZOAL AGENTS;
BOLIVIA;
CHILD;
FEMALE;
HUMANS;
LEISHMANIA BRAZILIENSIS;
LEISHMANIASIS, CUTANEOUS;
MALE;
MEGLUMINE;
MIDDLE AGED;
ORGANOMETALLIC COMPOUNDS;
PHOSPHORYLCHOLINE;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 41249087024
PISSN: 00029637
EISSN: None
Source Type: Journal
DOI: 10.4269/ajtmh.2008.78.210 Document Type: Article |
|
Times cited : (114)
|
|
References (6)
|
